Search
for
Sort by
Research 211–240 of 1000+
- Comparative Efficacy and Safety of Baricitinib Against Traditional Therapies in Severe Alopecia Areata: A Retrospective Cohort Study
- A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis
- 1368 Effects of phototherapy on refractory alopecia areata
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm
- BH21 Efficacy and safety of oral Janus kinase inhibitors in the treatment of alopecia areata: a systematic review and meta-analysis
- Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results
- Effectiveness and safety of baricitinib in severe alopecia areata: 48‐week results
- Patterns and predictors of Quality-of-Life impairment in alopecia areata: A cross-sectional analysis from south India
- BH31 Ritlecitinib for severe alopecia areata: does regional prescribing match national guidance?
- Baricitinib for the Treatment of Alopecia Areata
- Real-Life Effectiveness and Tolerance of Baricitinib for the Treatment of Severe Alopecia Areata with 1-Year Follow-Up Data
- Alopesia universalis pada anak yang berespon baik dengan terapi kombinasi: sebuah laporan kasus
- BH20 An unintended sequela of hair regrowth: severe Janus kinase inhibitor-associated acneiform eruption in alopecia areata
- Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
- Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis
- Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- Objective outcome measures: Collecting meaningful data on alopecia areata
- Topical Calcipotriol Therapy for Mild-to-Moderate Alopecia Areata: A Retrospective Study.
- Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents
- Bilateral Half-Head Comparison of 1% Anthralin Ointment in Children with Alopecia Areata
- Binding Interactions of Keratin-Based Hair Fiber Extract to Gold, Keratin, and BMP-2
- Efficacy of Postbiotics in a PRP-Like Cosmetic Product for the Treatment of Alopecia Area Celsi: A Randomized Double-Blinded Parallel-Group Study
- Clinical experiences on alopecia areata treatment with tofacitinib: A study of 63 patients
- Congenital adrenal hyperplasia
- Extensive alopecia areata: Not necessarily recalcitrant to therapy!
- Response of alopecia areata of the beard to oral tofacitinib
- Wharton’s jelly-derived mesenchymal stem cells in the treatment of four patients with alopecia areata